AG真人百家乐

Toumai^®'s completion of 100 cases of 5G tele-surgery

Toumai™ has completed the world’s first cross-border 5G ultra-remote simulated surgery verification

Toumai™ Robot Has Completed The World's First "World-Tour" Robotic Tele-Surgery Operation Verification

Toumai^® Completed the First Human Surgery In Overseas Markets

Toumai^® Completes 2,000 Clinical Surgeries

SkyWalker^® Orthopedic Surgical Robot global surgical volume exceeds a thousand cases

Toumai^® Laparoscopic Surgical Robot System Receives EU CE Certification

SkyWalker™ Orthopedic Surgical Robot completed FIM research of knee joint single condyle replacement (First in man, FIM)
Toumai^® Laparoscopic Surgical Robot completed China's first 5G ultra Telerobotics hepatobiliary surgery
Toumai^® Single-arm Surgical Robot completed the first gynecological registered clinical trial
SkyWalker™ Orthopedic Surgical Robot won the 2023 German iF Design Award
SkyWalker™ Orthopedic Surgical Robot approved for market by the Brazilian Health Supervision Authority (ANVISA)
Navibot^® knee Joint replacement surgery planning software was certified by NMPA
Mona Lisa Prostate Puncture Robot Positioning System Approved for Market by NMPA
AG百家乐^® Won First Prize of Shanghai Science and Technology Progress Award
Toumai^® Laparoscopic Surgical Robot completed the world's first 5G ultra Telerobotics hepatectomy
DFVision^® Endoscope has obtained EU CE certification
SkyWalker™ Orthopedic Surgical Robots have completed over 500 robot assisted clinical validation surgeries
Toumai^® Laparoscopic Surgical Robot complete over 1000 robot assisted clinical validation surgeries
Toumai^® Laparoscopic Surgical Robot completed the world's first 5G ultra Telerobotics assisted complete hysterectomy of double appendages
Toumai^® Laparoscopic Surgical Robot Completed the world's first 5G Telerobotics assisted radical prostatectomy (RALRP)
Toumai^® Laparoscopic Surgical Robot is approved by NMPA for multi-department applications
Mona Lisa received NMPA Approval
2nd DFVision® 3D Electronic Laparoscope received NMPA Approval
SkyWalker™ Hip and Knee Joint Replacement Robot  Received NMPA certification
Toumai^® Laparoscopic Surgical Robot is approved by NMPA for multi-department application

Toumai® Laparoscopic Surgical Robot completes Multi-Disciplinary and Multi-Center Clinical Trial.

Toumai^® Laparoscopic Surgical Robot was approved by the National Medical Products Administration and becomed the first domestic four-arm laparoscopic surgical robot to be put into clinic applications.

MicroPort® Honghu Orthopedic Surgical Robot was approved by NMPA, and became the first Chinese-developed orthopedic surgical robot equipped with robotic arms of independent intellectual property rights。

Toumai^® becomes the first laparoscopic robot in Asia to win the Red Dot Award of Germany.

Honghu received the approval from the U.S. Food and Drug Administration (FDA).

R-ONE™ has completed a multicenter clinical trial.

DFVision® 3D Electronic Laparoscope was awarded the "Top 10 Medical Devices List" in the 14th Health China Forum.

Toumai® Laparoscopic Surgical Robot Won the Highest honor of the 2022 WAIC——SAIL Award.

Toumai® Completes the World's Longest-Range 5G Tele-Robotic Surgery.

Honghu has become the first joint replacement robot in China to receive the European CE certification.

Established joint ventures with Robocath, NDR and Biobot in China

Completed the confirmatory clinical trial in urological surgery with Toumai^® Laparoscopic Surgical Robot and submitted the registration application to the National Medical Products Administration (NMPA)

The company was officially renamed as Shanghai MicroPort AG百家乐 (Group) Co., Ltd.

DFVision^® 3D Electronic Laparoscope was approved by the NMPA for commercialisation

MicroPort^® AG百家乐^® Debuts on Main Board of HKEX

Honghu Orthopedic Surgical Robot was admitted to the special review and approval procedure for innovative medical devices by NMPA(National Medical Products Administration)

Conducted the confirmatory clinical trial in urological surgery with Toumai^® Laparoscopic Surgical Robot

First robot-assisted partial nephrectomy completed by Toumai^® Laparoscopic Surgical Robot 

First robot-assisted partial nephrectomy completed through retroperitoneal approach by Toumai^® Laparoscopic Surgical Robot

Toumai^® Laparoscopic Surgical Robot completed the first  domestic robot-assisted single-port partial nephrectomy

Microport^®, together with its subsidiary Microport^® AG百家乐, signed the external financing agreements, and introduced a number of well-known strategic investors including Zhuhai Gao Ling, CPE, Grand Flight, Creedfont Capital and Biolink Investment.

Established strategic partnership with Robocath in France,  NDR Medical Technology and Biobot Surgical Ltd, Singapore.

DFVision^® 3D Electronic Laparoscope was admitted to the special review and approval procedure for innovative medical devices by NMPA(National Medcal Products Administration)

Toumai^® Laparoscopic Surgical Robot was admitted to the special review and approval procedure for innovative medical devices by NMPA(National Medcal Products Administration)

Toumai^® Laparoscopic Surgical Robot completed the first-in-human (FIM) trial

DFVision^® 3D Electronic Laparoscope completed thr first-in-human (FIM) trial

Finalized the design of Toumai^® Laparoscopic Surgical Robot

Took the lead in formulating the first national standard on surgical robots

Finalized the design of DFVision^® 3D Electronic Laparoscope

Toumai^® Laparoscopic Surgical Robot successfully completed the preclinical trial on animals.

MicroPort (Shanghai) AG百家乐 Co., Ltd. was registered and incorporated

Started the feasibility study of Honghu Orthopedic Surgical Robot

Established the surgical robot project team and the preliminary R&D team